Benefits and risks of the subcutaneous immunotherapy with acari extracts in allergic rhinoconjunctivitis and bronchial asthma

Benefits and risks of the subcutaneous immunotherapy with acari extracts in allergic rhinoconjunctivitis and bronchial asthma

The records of patients from the Allergology Service in the Previsora Policlinic, Camagüey were revised to evaluate benefits and risks of the subcutaneous immunotherapy (ITSC) with extracts of acari. The study was observational, analytic and retrospective of cases and controls in allergic rhinoco...

Full description

Bibliographic Details
Main Authors:	Olimpio Rodríguez-Santos, Rodolfo Celio-Murillo, Alfredo Martin Laurrabaquio-Miranda
Format:	Article
Language:	English
Published:	Finlay Ediciones 2014-12-01
Series:	VacciMonitor
Subjects:	immunotherapy acari asthma rhinoconjunctivitis
Online Access:	http://scielo.sld.cu/scielo.php?script=sci_pdf&pid=S1025-028X2014000300007&lng=es&nrm=iso&tlng=es

Similar Items

Comparison of individual-level and population-level risk factors for rhinoconjunctivitis, asthma, and eczema in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three
by: Charlotte E. Rutter, et al.
Published: (2020-06-01)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
by: Thomas Proctor, et al.
Published: (2020-04-01)

Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
by: Anne K. Ellis, et al.
Published: (2021-12-01)

Prevalence of COVID-19 in children affected by allergic rhinoconjunctivitis and asthma: results from the second “SIAIP rhinosinusitis and conjunctivitis committee” survey
by: Giulia Brindisi, et al.
Published: (2022-01-01)

The immune system and the nature of immune disorders in patients with seasonal allergic rhinoconjunctivitis (sark) with moderate and severe
by: Alexey Kuznetsov
Published: (2020-09-01)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
by: Anne K. Ellis, et al.
Published: (2023-01-01)

Is allergic rhinitis a trivial disease?
by: Dirceu Solé, et al.
Published: (2011-01-01)

Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study
by: Rui Tang, et al.
Published: (2022-07-01)

Prevalence of asthma and allergic diseases in adolescents: nine‐year follow‐up study (2003‐2012)
by: Dirceu Solé, et al.
Published: (2015-01-01)

Characterization of dysbiosis of the conjunctival microbiome and nasal microbiome associated with allergic rhinoconjunctivitis and allergic rhinitis
by: Yuan Wang, et al.
Published: (2023-03-01)

Grand challenges in genetics and epidemiology of allergic diseases: from genome to exposome and back
by: Luis Garcia-Marcos
Published: (2024-02-01)

Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis
by: Ralph Mösges, et al.
Published: (2019-06-01)

Assessing serum cytokine and immunoglobulin levels in patients with allergic rhinitis and allergic rhinoconjunctivitis before and after treatment supplemented with macromycetes
by: V. K. Bogdanov, et al.
Published: (2023-11-01)

Intra-cervical lymphatic immunotherapy for dust mite-induced allergic rhinoconjunctivitis in children: a 3-year prospective randomized controlled trial
by: Qixing Wang, et al.
Published: (2023-08-01)

Clinical relevance of pre‐ and coseasonal sublingual immunotherapy with a 300 index of reactivity 5‐grass SLIT tablet in allergic rhinoconjunctivitis
by: Oliver Pfaar, et al.
Published: (2023-12-01)

Effect of infant viral respiratory disease on childhood asthma in a non‐industrialized setting
by: Jessica Atwell, et al.
Published: (2023-08-01)

IR (index of reactivity)-house dust mite sublingual immunotherapy liquid formulation for allergic rhinoconjunctivitis: Systematic review and meta-analysis of randomized and nonrandomized studies
by: Danilo Di Bona, MD, PhD, et al.
Published: (2024-05-01)

<i>C5</i> and <i>SRGAP3</i> Polymorphisms Are Linked to Paediatric Allergic Asthma in the Italian Population
by: Daria Messelodi, et al.
Published: (2022-01-01)

Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis
by: Anne M. Salapatek, et al.
Published: (2021-03-01)

Differences in allergen‐specific basophil activation and T cell proliferation in atopic dermatitis patients with comorbid allergic rhinoconjunctivitis treated with a monoclonal anti‐IL‐4Rα antibody or allergen‐specific immunotherapy
by: Anne‐Sophie Layritz, et al.
Published: (2023-04-01)

Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube®: a randomized clinical trial
by: Gomes PJ, et al.
Published: (2019-03-01)

Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis
by: Binoy Palathumpattu, et al.
Published: (2022-10-01)

A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II
by: Gianluigi Marseglia, et al.
Published: (2019-07-01)

Early childhood risk factors for rhinoconjunctivitis in adolescence: a prospective birth cohort study
by: Elisabeth Soegaard Christiansen, et al.
Published: (2017-04-01)

Prevalence of asthma, rhinitis and eczema among 13–14-year-old schoolchildren in Tochigi, Japan
by: Kumiya Sugiyama, et al.
Published: (2000-01-01)

Life assessment quality in patients allergic to outdoor allergens in the Banat area
by: Tamas Tudor Paul1,, et al.
Published: (2016-12-01)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
by: Sophia Tsabouri, et al.
Published: (2017-04-01)

Actual hyposensitizing therapy of allergic rhinitis
by: S. V. Morozova, et al.
Published: (2018-04-01)

Prevalence and risk factors associated with allergic rhinitis in Mexican school children: Global Asthma Network Phase I
by: Roberto García-Almaraz, et al.
Published: (2021-01-01)

Sublingual allergen immunotherapy for respiratory allergy: a systematic review
by: Carlos Blanco, et al.
Published: (2018-11-01)

Corrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
by: Sophia Tsabouri, et al.
Published: (2017-09-01)

Update about Oralair® as a treatment for grass pollen allergic rhinitis
by: L. Klimek, et al.
Published: (2022-11-01)

The Pattern of Sensitisation to Inhalant Allergens in Omani Patients with Asthma, Allergic Rhinitis and Rhinoconjunctivitis
by: Salem H Al-Tamemi, et al.
Published: (2008-11-01)

NEW ORIGINAL ANTIHISTAMINE BILASTINE IN THE TREATMENT OF ALLERGIC RHINITIS
by: A. A. Krivopalov, et al.
Published: (2017-11-01)

Feather mites (Acari: Astigmata) of captive Psittaciformes in Brazil
by: D.M. Pereira, et al.

Occurrence of Struthiopterolichus bicaudatus (Acari; Pterolichidae) in Southeastern Brazil Ocorrência de Struthiopterolichus bicaudatus (Acari; Pterolichidae) no sudeste brasileiro
by: J.L.H. Faccini, et al.
Published: (2006-10-01)

Smoking and prevalence of allergic disorders in Japanese pregnant women: baseline data from the Kyushu Okinawa Maternal and Child Health Study
by: Tanaka Keiko, et al.
Published: (2012-03-01)

New possibilities of pathogenetic therapy for allergic rhinitis
by: A. A. Krivopalov, et al.
Published: (2018-11-01)

South African Acari. IV. Some Mites of the Addo Elephant National Park
by: E.A. Ueckermann, et al.
Published: (1988-10-01)

Risk Factors for Wheezing, Eczema and Rhinoconjunctivitis in the Previous 12 Months among Six-Year-Old Children in Himeji City, Japan: Food Allergy, Older Siblings, Day-Care Attendance and Parental Allergy History
by: Fumitake Kurosaka, et al.
Published: (2011-01-01)